Trial
NCT00426127
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Iowa
Collaborators
Aventis Pharmaceuticals
Condition
Pancreatic Cancer
Intervention
Docetaxel
Why stopped
Inadequate number of eligible patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-29